Birmingham, AL, United States of America

Amit Gaggar

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2013-2025.


% Patents Active = 100.0


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Homewood, AL (US) (2013)
  • Birmingham, AL (US) (2021 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Amit Gaggar

Introduction

Amit Gaggar is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of respiratory health through his innovative patents. With a total of 4 patents, Gaggar's work focuses on improving treatments for lung diseases.

Latest Patents

One of his latest patents is titled "Inhaled respiratory probiotics for lung diseases of infancy, childhood and adulthood." This invention characterizes the respiratory microbiomes of neonates and individuals with bronchopulmonary disease. The patent provides probiotic compositions that include at least one living bacterial strain and at least one killed bacterial strain. These compositions can be delivered to the bronchi or lungs of a patient, potentially reducing the symptoms of bronchopulmonary diseases.

Career Highlights

Amit Gaggar is associated with the UAB Research Foundation at the University of Alabama at Birmingham. His work at this institution has allowed him to explore innovative solutions for respiratory health challenges.

Collaborations

Gaggar has collaborated with notable colleagues such as Charitharth Vivek Lal and Namasivayam Ambalavanan. Their combined expertise contributes to the advancement of research in respiratory health.

Conclusion

Amit Gaggar's innovative work in the field of respiratory health showcases his commitment to improving patient outcomes. His patents reflect a deep understanding of microbiomes and their potential impact on lung diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…